Literature DB >> 6153206

The sequential release of granule constitutents from human neutrophils.

B J Bentwood, P M Henson.   

Abstract

The degranulation response of human neutrophils to the calcium ionophore A23187, serum opsonized zymosan (ZC), aggregated gamma-globulin (A gamma G), C5a, formyl-methionyl-leucyl-phenylalanine (FMLP), and PMA has been studied as a reaction time course in order to compare the release kinetics of the separate granule types. Cell suspensions were treated with submaximal doses of stimuli for various time intervals, and the isolated supernatants were assayed for granule constituents. Lactoferrin (LF), a unique specific (secondary) granule protein, was measured by radioimmune assay, and the azurophil (primary) granule components, myeloperoxidase (MPO) and beta-glucuronidase (beta-glu), by enzymatic activity. A sequential pattern of first LF release followed by MPO and beta-glu was demonstrated with each of the stimuli examined, with or without cytochalasin B pretreatment. These kinetic studies demonstrate that the extracellular release of the specific and azurophil granules occur sequentially in human neutrophils with both soluble and particulate stimuli. These findings support the concept that the two granule types are subject to separate controlling factors.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6153206

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  67 in total

1.  Leukocytic cell sources of airway tissue kallikrein.

Authors:  Isabel T Lauredo; Rosanna M Forteza; Yelena Botvinnikova; William M Abraham
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-12-05       Impact factor: 5.464

2.  The significance of functional receptor heterogeneity in the biological responses of the rabbit neutrophil to stimulation by chemotactic formyl peptides.

Authors:  J C Kermode; R J Freer; E L Becker
Journal:  Biochem J       Date:  1991-06-15       Impact factor: 3.857

3.  RNA interference against CFTR affects HL60-derived neutrophil microbicidal function.

Authors:  Ryan W Bonvillain; Richard G Painter; Daniel E Adams; Anand Viswanathan; Nicholas A Lanson; Guoshun Wang
Journal:  Free Radic Biol Med       Date:  2010-09-24       Impact factor: 7.376

4.  Stimulation of neutrophil elastase and myeloperoxidase release by IgG fragments.

Authors:  I Eckle; G Kolb; C Heiser; K Havemann
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

5.  Rab27a and Rab27b regulate neutrophil azurophilic granule exocytosis and NADPH oxidase activity by independent mechanisms.

Authors:  Jennifer L Johnson; Agnieszka A Brzezinska; Tanya Tolmachova; Daniela B Munafo; Beverly A Ellis; Miguel C Seabra; Hong Hong; Sergio D Catz
Journal:  Traffic       Date:  2009-12-17       Impact factor: 6.215

6.  Molecular forms of myeloperoxidase in human plasma.

Authors:  R L Olsen; T K Steigen; T Holm; C Little
Journal:  Biochem J       Date:  1986-07-15       Impact factor: 3.857

Review 7.  Molecular imaging of fibrosis: recent advances and future directions.

Authors:  Sydney B Montesi; Pauline Désogère; Bryan C Fuchs; Peter Caravan
Journal:  J Clin Invest       Date:  2019-01-02       Impact factor: 14.808

8.  Dermatitis herpetiformis: effects of sulfones and sulfonamides on neutrophil myeloperoxidase-mediated iodination and cytotoxicity.

Authors:  J A Kazmierowski; J E Ross; D S Peizner; K D Wuepper
Journal:  J Clin Immunol       Date:  1984-01       Impact factor: 8.317

9.  Mechanisms of degranulation in neutrophils.

Authors:  Paige Lacy
Journal:  Allergy Asthma Clin Immunol       Date:  2006-09-15       Impact factor: 3.406

10.  Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans.

Authors:  Constantin F Urban; David Ermert; Monika Schmid; Ulrike Abu-Abed; Christian Goosmann; Wolfgang Nacken; Volker Brinkmann; Peter R Jungblut; Arturo Zychlinsky
Journal:  PLoS Pathog       Date:  2009-10-30       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.